Li, F.; Shao, X.; Liu, D.; Jiao, X.; Yang, X.; Yang, W.; Liu, X.
Vascular Disruptive Hydrogel Platform for Enhanced Chemotherapy and Anti-Angiogenesis through Alleviation of Immune Surveillance. Pharmaceutics 2022, 14, 1809.
https://doi.org/10.3390/pharmaceutics14091809
AMA Style
Li F, Shao X, Liu D, Jiao X, Yang X, Yang W, Liu X.
Vascular Disruptive Hydrogel Platform for Enhanced Chemotherapy and Anti-Angiogenesis through Alleviation of Immune Surveillance. Pharmaceutics. 2022; 14(9):1809.
https://doi.org/10.3390/pharmaceutics14091809
Chicago/Turabian Style
Li, Fasheng, Xinmei Shao, Dehui Liu, Xiaogang Jiao, Xinqi Yang, Wencai Yang, and Xiaoyan Liu.
2022. "Vascular Disruptive Hydrogel Platform for Enhanced Chemotherapy and Anti-Angiogenesis through Alleviation of Immune Surveillance" Pharmaceutics 14, no. 9: 1809.
https://doi.org/10.3390/pharmaceutics14091809
APA Style
Li, F., Shao, X., Liu, D., Jiao, X., Yang, X., Yang, W., & Liu, X.
(2022). Vascular Disruptive Hydrogel Platform for Enhanced Chemotherapy and Anti-Angiogenesis through Alleviation of Immune Surveillance. Pharmaceutics, 14(9), 1809.
https://doi.org/10.3390/pharmaceutics14091809